US FDA Approves Pfizer Covid-19 Vaccine Booster Shots for 5-11 Year Kids


On Tuesday, 17th May 2022, the Food and Drug Administration (FDA) of the United States has approved a booster dose of the corona virus vaccine developed by Pfizer and BioNTech for the children in the age group of 5 to 11 years.

The children in the particular age group can possibly get a covid-19 vaccine booster shot at least five months after they have received their primary vaccine series of two doses. The booster covid-19 shot has 10 micrograms, which is the same dosage as the primary series of the vaccine for the age group and a third of the vaccine dose is given to the people of 12 years and above.

The decision of the US FDA is now going to go to the Centers for Disease Control and Prevention (CDC) of the United States which is going to be making a recommendation about how the boosters should possibly be used for the age group. The Advisory Committee on Immunization Practices of the US CDC is now expected for discussing the booster during a scheduled meeting and Dr. Rochelle Walensky is also expected to issue a final recommendation followed by the meeting and the vaccine shots can start as early as 20th May 2022.

See also  US Court Reinstates Joe Biden’s Covid-19 Vaccine Mandate for Federal Employees

Dr. Peter Marks, top vaccine regulator of US FDA said that, the parents can now protect their children from the potential severe consequences of the novel corona virus by getting them fully vaccinated with the primary series of the two doses.